386 related articles for article (PubMed ID: 25650136)
1. Untangling knots between autophagic targets and candidate drugs, in cancer therapy.
Xie T; Li SJ; Guo MR; Wu Y; Wang HY; Zhang K; Zhang X; Ouyang L; Liu J
Cell Prolif; 2015 Apr; 48(2):119-39. PubMed ID: 25650136
[TBL] [Abstract][Full Text] [Related]
2. 6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells.
Zhao Y; Fan D; Ru B; Cheng KW; Hu S; Zhang J; Li ET; Wang M
Eur J Cancer; 2016 Nov; 68():38-50. PubMed ID: 27710830
[TBL] [Abstract][Full Text] [Related]
3. Autophagic pathways as new targets for cancer drug development.
Liu B; Cheng Y; Liu Q; Bao JK; Yang JM
Acta Pharmacol Sin; 2010 Sep; 31(9):1154-64. PubMed ID: 20694022
[TBL] [Abstract][Full Text] [Related]
4. Targeting autophagy to overcome drug resistance in cancer therapy.
Kumar A; Singh UK; Chaudhary A
Future Med Chem; 2015 Aug; 7(12):1535-42. PubMed ID: 26334206
[TBL] [Abstract][Full Text] [Related]
5. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
6. Targeting autophagic pathways for cancer drug discovery.
Liu B; Bao JK; Yang JM; Cheng Y
Chin J Cancer; 2013 Mar; 32(3):113-20. PubMed ID: 22835386
[TBL] [Abstract][Full Text] [Related]
7. Key autophagic targets and relevant small-molecule compounds in cancer therapy.
Tong XP; Chen Y; Zhang SY; Xie T; Tian M; Guo MR; Kasimu R; Ouyang L; Wang JH
Cell Prolif; 2015 Feb; 48(1):7-16. PubMed ID: 25474301
[TBL] [Abstract][Full Text] [Related]
8. Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents.
Zhang X; Chen LX; Ouyang L; Cheng Y; Liu B
Cell Prolif; 2012 Oct; 45(5):466-76. PubMed ID: 22765290
[TBL] [Abstract][Full Text] [Related]
9. BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells.
Goulielmaki M; Koustas E; Moysidou E; Vlassi M; Sasazuki T; Shirasawa S; Zografos G; Oikonomou E; Pintzas A
Oncotarget; 2016 Feb; 7(8):9188-221. PubMed ID: 26802026
[TBL] [Abstract][Full Text] [Related]
10. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
11. Rotenone induces apoptosis in human lung cancer cells by regulating autophagic flux.
Hu W; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M; Hao B; Shan S
IUBMB Life; 2016 May; 68(5):388-93. PubMed ID: 27015848
[TBL] [Abstract][Full Text] [Related]
12. Prucalopride inhibits the glioma cells proliferation and induces autophagy via AKT-mTOR pathway.
Qiao H; Wang YB; Gao YM; Bi LL
BMC Neurol; 2018 Jun; 18(1):80. PubMed ID: 29866060
[TBL] [Abstract][Full Text] [Related]
13. α-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in mice.
Wang F; Ma H; Liu Z; Huang W; Xu X; Zhang X
Biomed Pharmacother; 2017 Aug; 92():672-680. PubMed ID: 28582759
[TBL] [Abstract][Full Text] [Related]
14. Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents.
Sun H; Wang Z; Yakisich JS
Anticancer Agents Med Chem; 2013 Sep; 13(7):1048-56. PubMed ID: 23293890
[TBL] [Abstract][Full Text] [Related]
15. Core signaling pathways of survival/death in autophagy-related cancer networks.
Wang SY; Yu QJ; Zhang RD; Liu B
Int J Biochem Cell Biol; 2011 Sep; 43(9):1263-6. PubMed ID: 21640844
[TBL] [Abstract][Full Text] [Related]
16. Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target.
Radogna F; Dicato M; Diederich M
Biochem Pharmacol; 2015 Mar; 94(1):1-11. PubMed ID: 25562745
[TBL] [Abstract][Full Text] [Related]
17. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling.
Chang CH; Lee CY; Lu CC; Tsai FJ; Hsu YM; Tsao JW; Juan YN; Chiu HY; Yang JS; Wang CC
Int J Oncol; 2017 Mar; 50(3):873-882. PubMed ID: 28197628
[TBL] [Abstract][Full Text] [Related]
19. Nutrient-sensing mTORC1: Integration of metabolic and autophagic signals.
Tan VP; Miyamoto S
J Mol Cell Cardiol; 2016 Jun; 95():31-41. PubMed ID: 26773603
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells.
Hu JL; Hu XL; Guo AY; Wang CJ; Wen YY; Cang SD
Oncotarget; 2017 Jul; 8(30):49380-49394. PubMed ID: 28537902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
